BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 6358482)

  • 21. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
    Zhang JG; Zhong L; Li CL
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
    [No Abstract]   [Full Text] [Related]  

  • 22. Patients with breast cancer and positive sentinel nodes: axillary dissection or axillary radiotherapy?
    Zippel D; Papa M
    Arch Surg; 2003 Oct; 138(10):1159. PubMed ID: 14557139
    [No Abstract]   [Full Text] [Related]  

  • 23. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
    Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Axillary regional recurrence after sentinel lymph node biopsy for breast cancer.
    Rosing DK; Dauphine CE; Vargas MP; Gonzalez K; Burla M; Kaufmann P; Vargas HI
    Am Surg; 2006 Oct; 72(10):939-42. PubMed ID: 17058740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of axillary recurrence after axillary lymph node dissection for invasive breast cancer.
    Voogd AC; de Boer R; van der Sangen MJ; Roumen RM; Rutten HJ; Coebergh JW
    Eur J Surg Oncol; 2001 Apr; 27(3):250-5. PubMed ID: 11373100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolated retromammary lymph node metastasis of breast cancer without axillary lymph node involvement: a case report with a false-negative sentinel lymph node biopsy.
    Rokutanda N; Horiguchi J; Koibuchi Y; Nagaoka R; Sato A; Odawara H; Tokiniwa H; Iino Y; Hirato J; Takeyoshi I
    Breast Cancer; 2009; 16(2):162-5. PubMed ID: 19242778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
    Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS
    J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-axillary breast cancer recurrences after sentinel node biopsy.
    van Rijk MC; Nieweg OE; Valdés Olmos RA; Rutgers EJ; Hoefnagel CA; Kroon BB
    J Surg Oncol; 2005 Dec; 92(4):292-8. PubMed ID: 16299804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The evolution of lymph node assessment in breast cancer.
    Quan ML; McCready D
    J Surg Oncol; 2009 Mar; 99(4):194-8. PubMed ID: 19021226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lymphogenic metastasis of breast carcinoma].
    Schremmer CN; Kochem HG
    Z Lymphol; 1979 Jun; 3(1):5-8. PubMed ID: 539065
    [No Abstract]   [Full Text] [Related]  

  • 32. Is axillary dissection needed in node-positive breast cancer?
    Greenberg CC; Bafford AC; Golshan M
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):195-8. PubMed ID: 18279060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lower nodal counts in axillary dissection following neoadjuvant chemotherapy: are there implications?
    Callcut RA; Breslin TM
    Am J Surg; 2006 Jun; 191(6):830-1. PubMed ID: 16720160
    [No Abstract]   [Full Text] [Related]  

  • 34. Lymph nodes in the tail of the breast can be missed in standard axillary dissection.
    Williams RN; Jones L; Stotter A
    Eur J Surg Oncol; 2009 Mar; 35(3):271-5. PubMed ID: 18407454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Commentary on Barranger et al., Contralateral axillary lymph node drainage in breast cancer: a case report: unusual lymph drainage pathways in patients with breast cancer.
    Nieweg OE; van Rijk MC; Tanis PJ; Estourgie SH
    J Surg Oncol; 2004 Aug; 87(2):105-6. PubMed ID: 15282705
    [No Abstract]   [Full Text] [Related]  

  • 36. [Breast cancer: axillary dissection--or an unnecessary procedure?].
    Schäfer P
    Schweiz Med Wochenschr; 1998 Oct; 128(43):1667-74. PubMed ID: 9842666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variability in axillary lymph node dissection for breast cancer.
    Schaapveld M; Otter R; de Vries EG; Fidler V; Grond JA; van der Graaf WT; de Vogel PL; Willemse PH
    J Surg Oncol; 2004 Jul; 87(1):4-12. PubMed ID: 15221913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metastases to the upper levels of the axillary nodes in carcinoma of the breast and its implications for nodal sampling procedures.
    Pigott J; Nichols R; Maddox WA; Balch CM
    Surg Gynecol Obstet; 1984 Mar; 158(3):255-9. PubMed ID: 6701738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Site size and significance of palpable metastatic and 'reactive' nodes in operable breast cancer.
    Black RB; Steele RJ; Collins WC; Forrest AP
    Clin Oncol; 1982 Jun; 8(2):127-35. PubMed ID: 7105523
    [No Abstract]   [Full Text] [Related]  

  • 40. [Detailed pathological examination of the sentinel lymph nodes in order to detect micrometastases: no clinical relevance in patients with breast cancer].
    Meijnen P; Peterse JL; Nieweg OE; Rutgers EJ
    Ned Tijdschr Geneeskd; 2004 Dec; 148(49):2428-32. PubMed ID: 15626306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.